Dr. Molina is a graduate of Stanford University in California and received his medical degree from Baylor College of Medicine in Houston, Texas. He completed an Internal Medicine residency at the University of Texas in San Antonio and conducted his fellowship in Hematology–Oncology at the Fred Hutchinson Cancer Research Center/University of Washington in Seattle.
As an experienced medical oncologist and cancer care provider, Dr. Molina has a special interest in clinical research and caring for patients while supporting their families. He considers both sides of medicine, pairing science and the latest clinical research on the one hand, with the human side and one’s overall wellbeing on the other hand. Dr. Molina enjoys working with patients and their families, helping them cope with the demanding challenges that a cancer diagnosis can bring.
In addition to traditional medical oncology therapy options, such as chemotherapy, Dr. Molina utilizes new cutting-edge treatment approaches like immunotherapies, which can offer patients a less toxic and more targeted way to treat their cancer. Immune and targeted therapies, which look at cancers at the molecular level, allow him to focus on treating these genetic mutations with more effectiveness and precision, with fewer side effects than traditional medical oncology treatments. Dr. Molina is invested in the revolution of cancer care and is excited for future medical advancements in cancer treatment.
Dr. Molina and his wife have 2 college-aged children. He enjoys travel, photography, nature-walks, hiking, as well as birding. Dr. Molina and his family were drawn to the area by the community feel and ability to be closer to nature.
Medical School:
Graduate Degree:
Residency:
Fellowship:
• American Board of Internal Medicine: Internal Medicine, Medical Oncology
D.G. Maloney, A. J. Molina, F. Sahebi, K.E. Stockerl-Goldstein, B.M. Sandmaier, W. Bensinger, B. Storer, D. Niederwieser, F.R. Appelbaum, K.G. Blume, S.J. Forman, P. McSweeney, A. Kashyap, T. Chauncey, B. Bruno, R. Storb, Nonmyeloablative Allografting following Cytoreductive Autografts for Treatment of Patients with Multiple Myeloma, Blood, Vol 102, No. 9 2003, 3447-3454.
P.A. McSweeney, D. Niederwieser, J. Shizuru, B.M. Sandmaier, A. J. Molina, D.G. Maloney, T.R. Chauncey, T.A. Gooley, U. Hegenbart, R.A. Nash, J.P. Radich, K.G. Blume, R.F. Storb. Hematopoietic Cell Transplantation in Older Patients With Hematologic Malignancies: Replacing High Dose Cytotoxic Therapy With Graft-Versus-Tumor Effects. Blood, Volume 97, No. 11, 2001, pp. 3390-3400.
A. Molina, R. Storb. Hematopoetic Stem Cell Transplantation in Older Adults. Chapter: Bone Marrow Transplantation Annual, Rowe, Lazarus, Carella (eds). Martin Duntz Publishers, 2000.
A. Molina, B. Sandmaier and R. Storb, Non-myeloablative Hematopoietic Stem Cell Allografting (review), Current Opinion in Organ Transplantation, Volume 5, Issue 4, pp. 366-371, Lippincott Williams & Wilkins, 2000.
B. M. Sandmaier, P.A. McSweeney, D Niederwieser, D.G. Maloney, K.G. Blume, A. Molina, J.Shizuru, T. R. Chauncey, G. Georges, J.M. Zaucha, M. Maris, A. Woolfrey, R. Storb, Posttransplant Immunosuppression – Canine Models and Clinical Application, (chapter in) Nonmyeloablated Stem Cell Trasnplantation, edited by S. Slavin, G. Giralt, publishers: Darwin Scientific Publishing, Oxfordshire, UK, 2000.
R. Storb, P. McSweeney, B. Sandmaier, R. Nash, G. Georges, David Maloney, A. Molina, T. Chauncey, C. Yu, M. Zaucha, K. Blume, J. Shizuru, D. Niederwierser. Allogeneic Hematopoietic Stem Cell Transplantation: From the Nuclear Age into the 21st Century, Transplantation Proceedings, Vol 32, Issue 7, pp.2548-2549, 2000.
R. Storb, P.A. McSweeney, B.M. Sandmaier, R.A. Nash, G. Georges, D.G. Maloney , A. Molina , T. Chauncey, C. Yu, M. Zaucha. Nonmyeloablative Conditioning Regimens for Allogeneic Hematopoietic Stem Cell Transplantation. Turkish Journal of Haematology, Supplement to Volume 16, No. 3, 1999.
D.G. Maloney, F. Sahebi, KE Stockerl-Goldstein, BM Sandmaier, A.J. Molina, W. Bensinger, PA McSweeney, BE Storer, D. Niederwieser, T Chauncey, FR Appelbaum, KG Blume, R Storb. Combing an Allogeneic Graft vs Myeloma Effect with High Dose Autologous Stem Cell Rescue in the Treatment of Multiple Myeloma. (Plenary Paper) Blood 98, No.11 (Suppl 1) 434a, #1822, 2001.
A Molina, F. Sahebi, D.G. Maloney, B.M. Sandmaier, P. McSweeney, A. Kashyap, W. Bensinger, T. Chauncey, F.R. Appelbaum, S.J. Forman, R. Storb. Nonmyeloablative PBSC Allografts Following Cytoreductive Autotransplants for Treatment of Multiple Myeloma. Blood 96 (Suppl. 1): 480a, #2063, 2000.
B.M. Sandmaier, D.G. Maloney, U. Hegenbart, P.A. McSweeney, J. Shizuru, F. Sahebi, T. Chauncey, J. Radich, M.Maris, A. Molina, K. Blume, S. Forman, D. Niederwieser, R. Storb. Nonmyeloablative Conditioning for HLA-Identical Related Allografts for Hematologic Malignancies. Blood 96 (Suppl. 1): 480a, #2063, 2000.
A. Molina, P. McSweeney, D. Neiderwierser, J. Shizuru, D. G. Maloney, B. Sandmaier, T. Chauncey, R. Nash, R. Storb. Degree of Early Donor T-cell Chimerism Predicts GVHD and Graft Rejection in Patients with Nonmyeloablative Hematopoietic Stem Cell Allografts. Bone Marrow Transplantation, #9, Vol.25 (suppl. 1), March, 2000.
A. Molina, P. McSweeney, D. G. Maloney, B. Sandmaier, J.L. Wagner, R. Nash, T. Chauncey, E. Bryant, R. Storb. Degree of Early Donor T-cell Chimerism Predicts GVHD and Graft Rejection in Patients With Nonmyeloablative Hematopoietic Stem Cell Allografts. Blood 94 (Suppl. 1): 394a, #1745, 1999.
A. Molina, P. McSweeney, B. Sandmaier, R. Nash, R. Storb. ABO Mismatch in the Nonmyeloablative Allogeneic Peripheral Blood Stem Cell (PBSC) setting. Blood 94 (Suppl. 1): 151a, #661, 1999.
A. Molina, P. McSweeney, D.G. Maloney, B. Sandmaier, B. Bensinger, R. Nash, F. Appelbaum, R. Storb. Non-Myeloablative Peripheral Blood Stem Cell (PBSC) Allografts Following Cytoreductive Autotransplants for Treatment of Multiple Myeloma. Blood 94 (Suppl. 1): 347a, #1551, 1999.
P. McSweeney, D. Niederwieser, J. Shizuru, A. Molina, J. Wagner, S. Minor, J. Radich, B. Sandmaier, D. Maloney, R. Nash, T. Chauncey, K. Blume, R. Storb. Outpatient Allografting With Minimally Myelosuppressive, Immunosuppressive Conditioning of Low-Dose TBI and Postgrafting Cyclosporine and Mycophenolate Mofetil. Blood 94 (Suppl. 1): 393a, #1742, 1999
